Aquatech

Several drugs are sparingly soluble in water. As a result, injectable solutions of such drugs are prepared using organic solvents like propylene glycol as co-solvent along with water. Incorporation of propylene glycol in the formulation causes pain at the site of injection, which is due to high viscosity of propylene glycol.

For the first time in the world, Diclofenac 75mg/1ml injection is introduced for the management of acute pain. Unlike conventional Diclofenac injections, 1ml Dynapar AQ injection can be given intra-deltoid as well.

Multicentric clinical studies have proven the efficacy and safety of 75mg/1ml Diclofenac injections. Bioequivalence studies show that Dynapar AQ 1ml injection offers higher bioavailability compared to conventional 3ml Diclofenac injections.

Studies have shown that majority of intra-gluteal injections may actually be subcutaneous and it is proven that the rate of absorption is faster when given intra-deltoid rather than intra-gluteal. Moreover, it is also known, that smaller volumes of concentrated solution cause less muscle damage as compared to larger volumes of relatively less concentrated solution.

back to Innovative Technologies